First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study.

ABSTRACT:

Background

In the present article, we present our first experiences with a new type of balloon-expandable Myval valve (Meril Life Sciences, Gujarat, India).

Materials and methods

A total of 25 consecutive patients who underwent transcatheter aortic valve implantation (TAVI) from June 2020 to November 2020 were included in the study.

Results

The mean age of the study population was 83 (75-87) years; 17 (68%) were female, and 20 (80%) had hypertension. The Society of Thoracic Surgeons (STS) score of the group was 5.4% ± 3.5%. TAVI was performed via the transfemoral route on all patients. In 19 (76%) cases, we started the procedure without predilation. In two (10.5%) cases performed without predilation, the prosthesis did not pass the native valve. We had to implant the

SUBMITTER: Akyuz AR 

PROVIDER: S-EPMC8512594 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature